John Rendu

2.3k total citations
48 papers, 944 citations indexed

About

John Rendu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cell Biology. According to data from OpenAlex, John Rendu has authored 48 papers receiving a total of 944 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 13 papers in Cardiology and Cardiovascular Medicine and 12 papers in Cell Biology. Recurrent topics in John Rendu's work include Muscle Physiology and Disorders (14 papers), Cellular transport and secretion (10 papers) and Cardiomyopathy and Myosin Studies (9 papers). John Rendu is often cited by papers focused on Muscle Physiology and Disorders (14 papers), Cellular transport and secretion (10 papers) and Cardiomyopathy and Myosin Studies (9 papers). John Rendu collaborates with scholars based in France, United States and Italy. John Rendu's co-authors include Julien Fauré, Charles Coutton, Joël Lunardi, Christophe Arnoult, Julie Delaroche, Didier Grünwald, Nicolas Thierry‐Mieg, Denise Escalier, Pierre F. Ray and Sandra Yassine and has published in prestigious journals such as Journal of Cell Science, Biophysical Journal and Journal of the American Society of Nephrology.

In The Last Decade

John Rendu

42 papers receiving 934 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Rendu France 16 497 279 204 177 167 48 944
David R.C. Natale Canada 24 920 1.9× 253 0.9× 143 0.7× 459 2.6× 77 0.5× 53 1.9k
Weihong Zhao China 15 402 0.8× 260 0.9× 55 0.3× 54 0.3× 21 0.1× 24 742
Albert de la Chapelle Finland 13 544 1.1× 477 1.7× 407 2.0× 406 2.3× 44 0.3× 15 1.3k
Mikihiro Yoshie Japan 21 276 0.6× 126 0.5× 339 1.7× 135 0.8× 44 0.3× 51 952
Ja‐Hyun Jang South Korea 17 382 0.8× 300 1.1× 58 0.3× 28 0.2× 48 0.3× 121 990
Xinhui Sun China 9 491 1.0× 37 0.1× 59 0.3× 120 0.7× 50 0.3× 22 961
Efrat Eliyahu United States 17 438 0.9× 91 0.3× 199 1.0× 298 1.7× 215 1.3× 36 1.2k
Julie Steffann France 23 809 1.6× 445 1.6× 54 0.3× 111 0.6× 81 0.5× 67 1.4k
Silvia Pulido United States 8 254 0.5× 92 0.3× 127 0.6× 106 0.6× 75 0.4× 12 547
Yuning Xiong United States 21 726 1.5× 166 0.6× 23 0.1× 31 0.2× 53 0.3× 31 1.2k

Countries citing papers authored by John Rendu

Since Specialization
Citations

This map shows the geographic impact of John Rendu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Rendu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Rendu more than expected).

Fields of papers citing papers by John Rendu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Rendu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Rendu. The network helps show where John Rendu may publish in the future.

Co-authorship network of co-authors of John Rendu

This figure shows the co-authorship network connecting the top 25 collaborators of John Rendu. A scholar is included among the top collaborators of John Rendu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Rendu. John Rendu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Benstaali, Caroline, Julie Brocard, Benoı̂t Giannesini, et al.. (2025). Limited pre-clinical relevance of the heterozygous RYR1-I4895T/+ mouse model due to its mild phenotype. Journal of Neuromuscular Diseases. 708646490–708646490.
2.
Brocard, Julie, Kamel Mamchaoui, Norma B. Romero, et al.. (2024). Functional benefit of CRISPR-Cas9-induced allele deletion for RYR1 dominant mutation. Molecular Therapy — Nucleic Acids. 35(3). 102259–102259. 1 indexed citations
3.
Brocard, Julie, et al.. (2024). Du gène à la cellule. médecine/sciences. 40. 30–33.
4.
Silva, Helga Cristina Almeida da, Nicol C. Voermans, Heinz Jungbluth, et al.. (2024). Myopathic manifestations across the adult lifespan of patients with malignant hyperthermia susceptibility: a narrative review. British Journal of Anaesthesia. 133(4). 759–767. 4 indexed citations
5.
Rendu, John, Laurence Michel‐Calemard, Rita Menassa, et al.. (2023). Muscular phenotype description of abnormal THOC2 splicing. Neuromuscular Disorders. 33(12). 978–982. 2 indexed citations
6.
Brocard, Julie, et al.. (2023). Gene therapy strategies using CRISPR/Cas9 for RyR1-related myopathies. Biophysical Journal. 122(3). 239a–240a.
7.
Marty, Isabelle, et al.. (2022). Gene therapies for RyR1-related myopathies. Current Opinion in Pharmacology. 68. 102330–102330. 2 indexed citations
8.
Petiot, Anne, et al.. (2022). Development of Knock-Out Muscle Cell Lines using Lentivirus-Mediated CRISPR/Cas9 Gene Editing. Journal of Visualized Experiments. 3 indexed citations
9.
Fauré, Julien, Jean-Michel Faure, A. Couture, et al.. (2022). Prenatal diagnosis of Lowe syndrome in a male fetus with isolated bilateral cataract. Heliyon. 8(12). e12210–e12210.
10.
Rendu, John, et al.. (2021). Therapies for RYR1-Related Myopathies: Where We Stand and the Perspectives. Current Pharmaceutical Design. 28(1). 15–25. 8 indexed citations
11.
Lasne, Dominique, Sonia Poirault‐Chassac, Tristan Mirault, et al.. (2021). Role of oculocerebrorenal syndrome of Lowe (OCRL) protein in megakaryocyte maturation, platelet production and functions: a study in patients with Lowe syndrome. British Journal of Haematology. 192(5). 909–921. 8 indexed citations
12.
Marchal, Stéphane, Norbert Chauvet, Amandine Guérin, et al.. (2021). Phenotypic switch of smooth muscle cells in paediatric chronic intestinal pseudo‐obstruction syndrome. Journal of Cellular and Molecular Medicine. 25(8). 4028–4039. 7 indexed citations
13.
Pelletier, Laurent, Anne Petiot, Julie Brocard, et al.. (2020). In vivo RyR1 reduction in muscle triggers a core-like myopathy. Acta Neuropathologica Communications. 8(1). 192–192. 15 indexed citations
14.
Rendu, John, Laurent Pelletier, Julie Brocard, et al.. (2020). Variations in the TRPV1 gene are associated to exertional heat stroke. Journal of science and medicine in sport. 23(11). 1021–1027. 9 indexed citations
15.
Marguet, Florent, John Rendu, Catherine Vanhulle, et al.. (2019). Association of fingerprint bodies with rods in a case with mutations in the LMOD3 gene. Neuromuscular Disorders. 30(3). 207–212. 6 indexed citations
16.
Giannesini, Benoı̂t, Julie Brocard, Mathilde Chivet, et al.. (2018). Deletion of the microtubule-associated protein 6 (MAP6) results in skeletal muscle dysfunction. Skeletal Muscle. 8(1). 30–30. 19 indexed citations
17.
Chauveau, Claire, Cédric Julien, Isabelle Duband‐Goulet, et al.. (2016). The transcription coactivator ASC-1 is a regulator of skeletal myogenesis, and its deficiency causes a novel form of congenital muscle disease. Human Molecular Genetics. 25(8). 1559–1573. 17 indexed citations
18.
Seferian, A., Edoardo Malfatti, Laurent Pelletier, et al.. (2016). Mild clinical presentation in KLHL40-related nemaline myopathy (NEM 8). Neuromuscular Disorders. 26(10). 712–716. 14 indexed citations
19.
Cacheux, Marine, Anne‐Sophie Wozny, Julie Brocard, et al.. (2015). Functional Characterization of a Central Core Disease RyR1 Mutation (p.Y4864H) Associated with Quantitative Defect in RyR1 Protein. Journal of Neuromuscular Diseases. 2(4). 421–432. 16 indexed citations
20.
Fourest‐Lieuvin, Anne, John Rendu, Daniela Rossi, et al.. (2012). Role of Triadin in the Organization of Reticulum Membrane at the Muscle Triad. Journal of Cell Science. 125(Pt 14). 3443–53. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David R.C. Natale Breakdown of academic impact, for papers by Weihong Zhao Breakdown of academic impact, for papers by Albert de la Chapelle Breakdown of academic impact, for papers by Mikihiro Yoshie Breakdown of academic impact, for papers by Ja‐Hyun Jang Breakdown of academic impact, for papers by Xinhui Sun Breakdown of academic impact, for papers by Efrat Eliyahu Breakdown of academic impact, for papers by Julie Steffann Breakdown of academic impact, for papers by Silvia Pulido Breakdown of academic impact, for papers by Yuning Xiong
Rankless by CCL
2026